Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Communications
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Poster Contest
      • Scholarships
    • Chapter Awards
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Communications
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Poster Contest
      • Scholarships
    • Chapter Awards
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
Startup Chroma Secures $135M to Advance Epigenetic Editing Technology

Startup Chroma Secures $135M to Advance Epigenetic Editing Technology

  • Posted by ISPE Boston
  • On March 9, 2023

Epigenetic editing pioneer Chroma Medicine has completed a $135 million Series B financing from a syndicate of investors led by GV (Google Ventures). The financing will support advancement of Chroma’s therapeutic programs toward the clinic and continued investment in the company’s core epigenetic editing platform.

“In the year since launch, we have made significant progress in advancing the pioneering work of our scientific founders towards harnessing the power of the cell’s epigenome to regulate gene expression and developing a robust portfolio of single-dose epigenetic editing therapeutics,” said Catherine Stehman-Breen, M.D., CEO of Chroma.

Current gene editing approaches regulate gene expression by cutting or nicking DNA, introducing risks associated with leveraging unpredictable DNA repair pathways. Chroma’s single-dose epigenetic editors harness the cells’ innate mechanism for gene regulation to precisely and durably silence, activate, and multiplex genes using a single platform, without changing the underlying DNA sequence. This groundbreaking approach enables Chroma to more effectively address a wide range of diseases and to target multiple pathways for complex diseases.

“Epigenetic editing opens the possibility of pursuing targets on the genome previously intractable with other therapeutic modalities; this includes the ability to target both protein coding and non-coding RNAs,” said Vic Myer, Ph.D., CSO of Chroma. “Our approach enables precise regulation while avoiding break-induced mutations, translocations, and rearrangements associated with other technologies, removing limitations on the number of simultaneous edits that are possible.”

“Genomic medicine is an exciting and fast-evolving field, and epigenetic editing has emerged as a promising new frontier for gene regulation,” said Issi Rozen, Venture Partner, GV. “Chroma’s technology enables durable modulation of gene expression – both individual genes and multiple genes at once – providing potentially transformative treatments for patients living with serious diseases.” (Source: Chroma Medicine Website, 01 March, 2023)

Share on Facebook Share
Share on TwitterTweet
Share on LinkedIn Share
Send email Mail
Print Print
 

0 Comments

Leave Reply Cancel reply

Leave a Comment

Your email address will not be published. Required fields are marked *

Post Categories
  • Industry Buzz (453)
  • Chapter News (422)
  • Knowledge & Training (73)
  • Students & YP (67)
  • Career Tools (11)
Get Updates via Email




Support our Sponsors

SmartLabs to Convert CambridgeSide Mall Space to Research Center

Previous thumb

Mediar Wins $105 Million Financing for Fibrosis Therapies

Next thumb
Scroll
Follow Us
Search this Site
@2021 ISPE Boston Chapter. All rights reserved.